Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gray

Showing results (861-870 of 929) with videos related to

Pageof 93
Sort By:
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
Oncotarget|December 22, 2017
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expressionAly-Khan A Lalani, Kathryn P Gray, Laurence Albiges, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney DiseaseEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
Hormones & Cancer|August 16, 2014
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersAnieta M Sieuwerts, Scooter Willis, Michael B Burns, et al.
Nature|September 7, 2001
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transductionK A Fitzgerald, E M Palsson-McDermott, A G Bowie, et al.
American Heart Journal|June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialMichael P Gray, Yemima Berman, Giordano Bottà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and CrizotinibAbhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.
Brain, Behavior, and Immunity|September 20, 2021
Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorderLaura J Westacott, Trevor Humby, Niels Haan, et al.
The Journal of Biological Chemistry|March 14, 2013
Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytesLawrence K Lee, Katherine J Bryant, Romaric Bouveret, et al.
Pageof 93

Showing results (861-870 of 929) with videos related to

Sort By:
Pageof 93
Journal of the American Society of Nephrology : JASN|February 11, 2014
Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathyJay C Jha, Stephen P Gray, David Barit, et al.
Oncotarget|December 22, 2017
Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expressionAly-Khan A Lalani, Kathryn P Gray, Laurence Albiges, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2018
Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney DiseaseEoin P Brennan, Muthukumar Mohan, Aaron McClelland, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
Hormones & Cancer|August 16, 2014
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancersAnieta M Sieuwerts, Scooter Willis, Michael B Burns, et al.
Nature|September 7, 2001
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transductionK A Fitzgerald, E M Palsson-McDermott, A G Bowie, et al.
American Heart Journal|June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialMichael P Gray, Yemima Berman, Giordano Bottà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and CrizotinibAbhishek Tripathi, Jeffrey G Supko, Kathryn P Gray, et al.
Brain, Behavior, and Immunity|September 20, 2021
Complement C3 and C3aR mediate different aspects of emotional behaviours; relevance to risk for psychiatric disorderLaura J Westacott, Trevor Humby, Niels Haan, et al.
The Journal of Biological Chemistry|March 14, 2013
Selective inhibition of human group IIA-secreted phospholipase A2 (hGIIA) signaling reveals arachidonic acid metabolism is associated with colocalization of hGIIA to vimentin in rheumatoid synoviocytesLawrence K Lee, Katherine J Bryant, Romaric Bouveret, et al.
Pageof 93